{"id":"https://openalex.org/W2761812588","doi":null,"title":"Combination of the VEGF receptor tyrosine kinase sunitinib and the mTOR inhibitor rapamycin leads to tumor regression in the RENCA model","display_name":"Combination of the VEGF receptor tyrosine kinase sunitinib and the mTOR inhibitor rapamycin leads to tumor regression in the RENCA model","publication_year":2008,"publication_date":"2008-05-01","ids":{"openalex":"https://openalex.org/W2761812588","mag":"2761812588"},"language":"en","primary_location":{"id":"mag:2761812588","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/68/9_Supplement/1104","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103085920","display_name":"Hans J. Hammers","orcid":"https://orcid.org/0000-0002-6224-4559","observed_orcids":["https://orcid.org/0000-0002-6224-4559"]},"institutions":[{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans J. Hammers","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD"],"raw_orcid":"https://orcid.org/0000-0002-6224-4559","affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD","institution_ids":["https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087954584","display_name":"Silvia Paesante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Silvia Paesante","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD","institution_ids":["https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100683846","display_name":"Li Shen","orcid":"https://orcid.org/0000-0001-8427-9448","observed_orcids":["https://orcid.org/0000-0001-8427-9448"]},"institutions":[{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Shen","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD"],"raw_orcid":"https://orcid.org/0000-0001-8427-9448","affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD","institution_ids":["https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015341987","display_name":"Michelle A. Rudek","orcid":"https://orcid.org/0000-0001-5739-6868","observed_orcids":["https://orcid.org/0000-0001-5739-6868"]},"institutions":[{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle A. Rudek","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD"],"raw_orcid":"https://orcid.org/0000-0001-5739-6868","affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD","institution_ids":["https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003107448","display_name":"\u0420\u043e\u0431\u0435\u0440\u0442\u043e \u041f\u0438\u043b\u0438","orcid":"https://orcid.org/0009-0004-9993-9911","observed_orcids":["https://orcid.org/0009-0004-9993-9911","https://orcid.org/0000-0002-5871-4896"]},"institutions":[{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"\u0420\u043e\u0431\u0435\u0440\u0442\u043e \u041f\u0438\u043b\u0438","raw_affiliation_strings":["Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD"],"raw_orcid":"https://orcid.org/0000-0002-5871-4896","affiliations":[{"raw_affiliation_string":"Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD","institution_ids":["https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210164401"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.45004313,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"68","issue":null,"first_page":"1104","last_page":"1104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.6812000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.6812000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.26030001044273376,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.03700000047683716,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7739999890327454},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9089999794960022},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.9430000185966492},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7260000109672546},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.7409999966621399},{"id":"https://openalex.org/keywords/renca-cells","display_name":"Renca cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.8610000014305115},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.925000011920929},{"id":"https://openalex.org/keywords/intratumoral-hemorrhage","display_name":"intratumoral hemorrhage","score":0.8930000066757202}],"concepts":[{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.9180150032043457},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6254481077194214},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6192880272865295},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5627322793006897},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5438060164451599},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5306609869003296},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.44379910826683044},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.43239057064056396},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42312371730804443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2975054383277893},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.26690125465393066},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2393818199634552},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.22861513495445251},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2761812588","doi":null,"is_oa":false,"landing_page_url":"https://cancerres.aacrjournals.org/content/68/9_Supplement/1104","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1970322471","https://openalex.org/W2003514175","https://openalex.org/W3083203681","https://openalex.org/W2024585022","https://openalex.org/W2024768794","https://openalex.org/W2123285648","https://openalex.org/W2088516219","https://openalex.org/W2315181489","https://openalex.org/W2563704563","https://openalex.org/W2035456008"],"abstract_inverted_index":{"1104":[0],"Introduction:":[2],"Tyrosine":[3],"kinase":[4],"inhibitors":[5,23,35],"such":[6],"as":[7,19,21,75,190,267,269],"sunitinib":[8,60,142,158,178,266,303,314],"targeting":[9],"angiogenesis":[10],"via":[11],"the":[12,26,40,57,83,102,167,174,194,217,245,249,265,271],"vascular":[13],"endothelial":[14],"growth":[15,129,162,186],"factor":[16,44],"(VEGF)":[17],"pathway,":[18],"well":[20,268],"mTOR":[22,34],"have":[24,36],"changed":[25],"medical":[27],"management":[28],"of":[29,42,51,59,139,208,227,251,300,313],"metastatic":[30],"renal":[31,71,90],"cell":[32,72,91,128],"carcinoma.":[33],"multiple":[37],"effects":[38],"including":[39],"downregulation":[41],"hypoxia-inducible":[43],"1":[45,228],"alpha":[46],"(HIF-1alpha),":[47],"a":[48,64,69,94,183,205,225,287,306],"key":[49],"regulator":[50],"angiogenesis.":[52],"Thus,":[53],"we":[54],"hypothesized":[55],"that":[56],"combination":[58,195,250,272,312],"and":[61,96,110,121,141,179,302,315,323,326],"rapamycin":[62,140,285,301,316],"has":[63],"greater":[65],"inhibitory":[66,163,168],"effect":[67,125,169],"in":[68,93,135,264,270,278,305],"murine":[70,89],"carcinoma":[73],"model":[74,152,176],"compared":[76,243],"to":[77,182,223,244,255,318],"single":[78,191,237],"agents.":[79,192],"Methods:":[80],"We":[81],"utilized":[82],"RENCA":[84],"cells,":[85],"an":[86,149,319],"aggressive":[87],"syngeneic":[88],"carcinoma,":[92],"prevention":[95,175,246],"intervention":[97,218],"model.":[98],"Tumor":[99],"weight":[100],"was":[101,113,130,211,232,276,296],"primary":[103],"endpoint.":[104],"Microvascular":[105],"density,":[106],"apoptosis,":[107],"proliferation,":[108],"hypoxia":[109],"fibrin":[111],"deposition":[112],"determined":[114,131],"by":[115,132],"cardiac":[116],"perfusion":[117],"with":[118,148,171,284],"thick":[119],"sectioning":[120],"confocal":[122],"analysis.":[123],"Direct":[124],"on":[126,213],"tumor":[127,185,198,209,256,321],"proliferation":[133],"assay":[134],"vitro.":[136],"Plasma":[137],"levels":[138,299],"were":[143,221,239,304],"obtained.":[144],"In":[145,156,173,193,216,234],"vivo":[146],"studies":[147],"orthotopic":[150],"xenograft":[151],"are":[153,329],"ongoing.":[154],"Results:":[155],"vitro,":[157],"had":[159],"no":[160,197],"direct":[161],"effect,":[164],"but":[165,204,248],"enhanced":[166],"seen":[170,212],"rapamycin.":[172],"both,":[177],"rapamycin,":[180],"lead":[181,254,317],"significant":[184,288],"inhibition":[187],"(>":[188],"90%)":[189],"group,":[196],"mass":[199,226],"could":[200],"be":[201],"appreciated":[202],"macroscopically,":[203],"scant":[206],"rim":[207],"cells":[210],"tissue":[214],"section.":[215],"study":[219],"tumors":[220],"allowed":[222],"reach":[224],"gram":[229],"before":[230],"treatment":[231,280,283],"initiated.":[233],"this":[235],"setting,":[236],"agents":[238,253],"less":[240],"effective":[241],"when":[242],"trial,":[247],"these":[252],"regression.":[257],"Histological":[258],"analyses":[259],"demonstrated":[260],"decreased":[261],"microvascular":[262],"density":[263],"treated":[273],"tumors.":[274],"Apoptosis":[275],"increased":[277],"all":[279],"groups.":[281],"The":[282,311],"induced":[286],"intratumoral":[289],"hemorrhage.":[290],"No":[291],"thrombocytopenia":[292],"or":[293],"platelet":[294],"dysfunction":[295],"observed.":[297],"Drug":[298],"plasma":[307],"achievable":[308],"range.":[309],"Conclusion:":[310],"unprecedented":[320],"regression":[322],"further":[324],"mechanistic":[325],"clinical":[327],"investigations":[328],"warranted":[330]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-10-20T00:00:00"}